Long-Term Vs. Short-Term Journal Impact: Does It Matter?

Date: February 2, 1998 Chart 1 Chart 2 The first published report on journal impact factors was included in E. Garfield, I.H. Sher, "New factors in the evaluation of scientific literature through citation indexing," American Documentation, 14[3]:195-201, July 1963. The late Irving H. Sher, who then was director of R&D at the Philadelphia-based Institute for Scientific Information (ISI), and I created the impact factor to help evaluate and select journals for Current Contents. The current i

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Date: February 2, 1998 Chart 1 Chart 2
The first published report on journal impact factors was included in E. Garfield, I.H. Sher, "New factors in the evaluation of scientific literature through citation indexing," American Documentation, 14[3]:195-201, July 1963. The late Irving H. Sher, who then was director of R&D at the Philadelphia-based Institute for Scientific Information (ISI), and I created the impact factor to help evaluate and select journals for Current Contents. The current impact factor is determined by counting citations in the current year's publications to papers published in the previous two years and dividing by the number of papers published in the same period. Editors often have complained that this measure, which records average influence in the first and second years after publication, is biased against journals in slow-moving fields. They have argued that measurement of long-term impact would show such journals in a better light.

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies